Pfizer Inc. logo

Pfizer Inc. (PFE)

Market Closed
12 Dec, 20:00
NYSE NYSE
$
25. 84
+0.04
+0.17%
$
146.18B Market Cap
14.55 P/E Ratio
1.68% Div Yield
45,007,403 Volume
1.43 Eps
$ 25.8
Previous Close
Day Range
25.72 26.04
Year Range
20.92 27.69
Want to track PFE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 51 days
Pfizer follows Eli Lilly's lead in direct-to-consumer push

Pfizer follows Eli Lilly's lead in direct-to-consumer push

Pfizer Inc. on Tuesday unveiled a new online platform designed to help simplify and coordinate healthcare for consumers, adding momentum to an emerging trend in big pharma that has drawn criticism from some provider groups and policy experts.

Marketwatch | 1 year ago
Is Pfizer Stock Still a Buy After an Unexpected Setback?

Is Pfizer Stock Still a Buy After an Unexpected Setback?

One of Pfizer's vaccine programs failed to demonstrate its utility. Its competitors had the same issue with their programs.

Fool | 1 year ago
FDA Approves Pfizer & Moderna's Updated COVID-19 Jabs

FDA Approves Pfizer & Moderna's Updated COVID-19 Jabs

On Thursday, the FDA cleared new versions of Pfizer's (PFE) and Moderna's (MRNA) COVID-19 vaccines that are designed to match COVID-19 strains currently circulating in the country.

Zacks | 1 year ago
3 Stocks Under $50 Smart Investors Should Buy Hand Over Fist

3 Stocks Under $50 Smart Investors Should Buy Hand Over Fist

It is never too early to start your investment journey.

247wallst | 1 year ago
New Pfizer and Moderna Covid-19 vaccines approved by US

New Pfizer and Moderna Covid-19 vaccines approved by US

US regulators have approved a new series of updated and improved COVID-19 vaccines to target a resurgence of the virus as new strains emerge. Pfizer Inc (NYSE:PFE, ETR:PFE) and Moderna Inc (NASDAQ:MRNA, ETR:0QF) are set to begin shipping immediately while a third US manufacturer, Novavax, expects to start deliveries later.

Proactiveinvestors | 1 year ago
Updated COVID-19 vaccines from Pfizer, Moderna approved by FDA

Updated COVID-19 vaccines from Pfizer, Moderna approved by FDA

The Food and Drug Administration on Thursday gave Pfizer Inc. and Moderna Inc. approval for updated COVID-19 vaccines, as a summer wave of the virus is still rolling across the country.

Marketwatch | 1 year ago
FDA approves updated Pfizer, Moderna Covid vaccines as virus surges; shots to be available within days

FDA approves updated Pfizer, Moderna Covid vaccines as virus surges; shots to be available within days

The Food and Drug Administration approved updated Covid vaccines from Pfizer and Moderna, putting the shots on track to reach most Americans in the coming days as the virus surges. The jabs target a strain called KP.2, a descendant of the highly contagious omicron subvariant JN.1 that began circulating widely in the U.S. earlier this year.

Cnbc | 1 year ago
Looking for $1500 in Safe Passive Income Each Year? Invest This Much in Pfizer.

Looking for $1500 in Safe Passive Income Each Year? Invest This Much in Pfizer.

24/7 Wall St. Insights Pfizer is one of the highest-yielding S&P 500 stocks.

247wallst | 1 year ago
Is Pfizer Stock A Buy Or A Sell With Covid-Era Growth In The Rearview?

Is Pfizer Stock A Buy Or A Sell With Covid-Era Growth In The Rearview?

Is Pfizer stock a buy or a sell as sales of its Covid products continue diving? Is PFE stock a buy or a sell right now?

Investors | 1 year ago
How Should You Play Pfizer (PFE) After COVID-Flu Shot Setback?

How Should You Play Pfizer (PFE) After COVID-Flu Shot Setback?

After Pfizer's (PFE) better-than-expected second-quarter results and the bullish outlook for the year, investors who own Pfizer's stock may consider staying invested.

Zacks | 1 year ago
2 Cheap Passive Income Stocks to Buy Now

2 Cheap Passive Income Stocks to Buy Now

Social Security faces potential benefit reductions after 2035. Dividend-paying stocks can form a solid basis for a passive income portfolio.

Fool | 1 year ago
Pfizer (PFE), BioNTech COVID-Flu Combo Shot Study Falters

Pfizer (PFE), BioNTech COVID-Flu Combo Shot Study Falters

Pfizer's (PFE) COVID and flu combination vaccine demonstrates a continued trend of higher responses against influenza A but fails to show non-inferiority against the influenza B strain.

Zacks | 1 year ago
Loading...
Load More